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We consider that from the wound to the healing process, the physiology point key to
linkage of the process is still unclear. The process from inﬂammation to the wound healing
is divided into three phases: (1) inﬂammation process, (2) tissue formation, and (3) tissue
remodeling.The inﬂammation program includes cell produced related factors and immune
cells inﬁltration. We thought the inﬂammation factors that may be also involved in the
followed healing process. But the question is “what kind of factor is the major key involved
in the end of the inﬂammation then to initiate the healing.”We suspect that the apoptosis
of immune cell may be the major key to end of inﬂammation and to initiate the healing.
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INTRODUCTION
Wound healing is a complex process involving soluble medi-
ators, blood cells, extracellular matrix, and parenchymal cells
(Singer and Clark, 1999; Bullers et al., 2012; Pesce et al., 2013).
The process from inﬂammation to the wound healing is divided
into three phases: (1) inﬂammation process, (2) tissue forma-
tion, and (3) tissue remodeling (Figure 1; Eming et al., 2007).
The inﬂammatory phase is marked by platelet accumulation,
coagulation, and leukocyte migration. The tissue formation is
characterized by re-epithelialization, angiogenesis, ﬁbroplasia, and
wound contraction. Finally, the remodeling phase takes place over
a period of months, during which the dermis responds to injury
with the production of collagen and matrix proteins and then
returns to its pre-injury phenotype (Kirsner and Eaglstein, 1993;
Castillo-Briceno et al., 2011; Bainbridge, 2013). The normal heal-
ing response begins the moment the tissue is injured. Peripheral
blood components ﬁltrated into the site of injury, the platelets
contact with exposed collagen and other elements of the extra-
cellular matrix through the process from inﬂammation to wound
healing (Diegelmann and Evans, 2004). This contact triggers the
platelets to release clotting factors as well as essential growth fac-
tors and cytokines such as platelet-derived growth factor (PDGF),
such as stimulationof DNAsynthesis and chemotaxis of ﬁbroblasts
moreover smooth muscle cells to induce the production of colla-
gen, glycosaminoglycan, and collagenase by ﬁbroblasts through
the wound healing process (Lynch et al., 1987; Price et al., 2004;
Tettamanti et al., 2004). Furthermore, PDGF appears to transduce
its signal through woundmacrophages andmay trigger the activa-
tion of feedback loops and synthesis of endogenous wound PDGF
and other growth factors, thereby enhancing the cascade of tis-
sue repair processes required for a fully healed wound (Pierce
et al., 1991). In a normal response to injury, platelet aggrega-
tion and degranulation of the earliest events in an inﬂammatory
response trigger the release of numerous inﬂammatory media-
tors including transforming growth factor-β (TGF-β) from the
granules (Wahl et al., 1989; Tatler and Jenkins, 2012; Christmann
et al., 2013). TGF-β is implicated in pathogenic ﬁbrotic conditions
in kidney, liver, and lung disease, and in scarring of skin wounds
as well (Martin, 1997; Sgonc and Gruber, 2013). Accumulating
evidence indicates that TGF-β affects integrin-mediated cell adhe-
sion and migration by regulating the expression of integrins, their
ligands and integrin-associated proteins (Margadant and Sonnen-
berg, 2010). Research indicated that a synthetic TGF-β is effective
in accelerating wound healing and reducing scarring in pig skin
burn, pig skin excision, and rabbit skin excision injury models
(Huang et al., 2002).
INFLAMMATION PROCESS
Inﬂammation is known to be a crucial adaptive response for ani-
mals, and the mechanism is a complex interaction with molecular
mediators even the functions of immune cells in a microenvi-
ronment through a response that occurs at all levels of biological
organization (Allavena et al., 2008). In this process, cooperation
among cells and mediators occurs, and a wide range of factors
are involved in the classical immune response, including the stage
of the inﬂammation process; the tissue or organ involved; and
whether the inﬂammation is acute and resolving or chronic and
non-resolving (Punchard et al., 2004). The inﬂammation process
involves vascular permeability, activemigration of blood cells, and
the passage of plasma constituents into injurious tissue (Maslin-
ska and Gajewski, 1998). Through the inﬁltration of immune
cells, studies have shown that the inﬂammation process plays a
crucial role in atherosclerosis (Sbarsi et al., 2007). Blood leuko-
cytes, mediators of host defenses and inﬂammation, localize in
the earliest lesions of atherosclerosis in experimental animals. The
study of inﬂammation in atherosclerosis has afforded consider-
able new insight into the mechanisms underlying the recruitment
of leukocytes (Libby et al., 2002). Recently, studies have indi-
cated the role of inﬂammation in Alzheimer’s disease (AD; Schott
and Revesz, 2013). Inﬂammatory components related to AD
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FIGURE 1 |The process from inflammation to the wound healing is
divided into three phases: (1) Inflammation process, (2) tissue
formation, and (3) tissue remodeling. The important question, “what is
the key linkage between the tissue formation and inﬂammation?”
neuroinﬂammation include brain cells, such as microglia and
astrocytes, the complement system, and cytokines and chemokines
(Rubio-Perez and Morillas-Ruiz, 2012). Regarding cancer devel-
opment (Gregory, 2013), pro-inﬂammatory cytokines, including
interleukin (IL)-1α, IL-1β, IL-6, IL-8, IL-18, chemokines, matrix
metallopeptidase (MMP)-9, and vascular endothelial growth fac-
tor (VEGF) are primarily regulated by the transcription factor
nuclear factor (NF)-kB, which is active in most tumors and is
induced by carcinogens (Aggarwal et al., 2006). Cutaneous wound
repair is a tightly regulated and dynamic process involving blood
clotting, inﬂammation, formationof new tissue, and tissue remod-
eling (Muller et al., 2012). Thrombin is the protease involved
in blood coagulation. Its deregulation can lead to hemostatic
abnormalities, which range from subtle subclinical to serious life-
threatening coagulopathies, i.e., during septicemia (Danckwardt
et al., 2013). Inﬂammation and blood coagulation are the part of
the innate host protectionmechanismon vascular injury, infection
or other wound. Not only the cell of the innate immune systembut
also activated endothelial cells and platelets are actively involved in
acute and chronic inﬂammation: they release of pro-inﬂammatory
mediators, expose adhesion molecules and receptors, proteases
and its inhibitors, clotting factors and associated proteins, and
recruit leukocytes (Strukova, 2006). In the process, PAR family
serve as sensors of serine proteinases of the blood clotting system
in the target cells involved in inﬂammation. Activation of PAR-1
by thrombin and of PAR-2 by factor leads to a rapid expression and
exposure on the membrane of endothelial cells of both adhesive
proteins that mediate an acute inﬂammatory reaction and of the
tissue factor that initiates the blood coagulation cascade.(Dugina
et al., 2002).
MEDIATORS OF INFLAMMATION
In the inﬂammation, microenvironment is related to cellular
trans-differentiation,migration, proliferation, survival, and extra-
cellular matrix formation. The growth factors likely to be involved
are PDGF, TNF-α and TNF-β, HGF, TGF-β2, epidermal growth
factor (EGF), and ﬁbroblast growth factor (FGF). Cytokines such
as IL-1, IL-6, IL-8, IL-10, and interferon gamma (INF-γ) are also
thought to play a role (Morescalchi et al., 2013). It is clearly a
balance between appropriate ﬁbroblast activation and the ﬁbro-
sis that results from their continuing activation. Multiple growth
factors have been implicated in ﬁbroblast migration and activa-
tion, but much attention has been recently focused on the PDGF
family of growth factors and their cognate receptors (PDGFRs;
Nemenoff, 2012). Research has documented that PDGF exerts
autocrine, mitogenic effect on keratinocytes to support epidermal
proliferation and stabilization of the dermoepidermal junction
during wound closure. In addition, it stimulates vessel mat-
uration by recruitment and differentiation of pericytes to the
immature-endothelial channels (Hellberg et al., 2010).
Studies have investigated the cytokines involved in the inﬂam-
mation response by using various animal models. The expression
of pro-inﬂammatory cytokines, such as tumor necrosis factor
alpha (TNF)-α, is signiﬁcantly increased in the adipocytes of
obese animals (ob/ob mouse, db/db mouse, and fa/fa Zucker rat;
Hotamisligil et al., 1993). The activation of TNF-α might induce
leukocytes express adhesion molecules on the cell surface (Dunne
et al., 2003; Bruderer et al., 2013; Li et al., 2013), leading to dia-
pedesis through individual vascular endothelial cells (Carman and
Springer, 2004). IL-6 is an adipokine (Fried et al., 1998) thought
to be a mediator of inﬂammation (Xing et al., 1998; Deng et al.,
2012; Tang et al., 2012) that is produced by adipose tissue and liver-
resident macrophages that are activated in response to hepatocyte
death (Sakurai et al., 2008). IL-6-deﬁcient mice exhibit a marked
decrease in inﬂammatory response, granulation tissue formation,
and re-epithelialization (Gallucci et al., 2000). The IL-1 family,
which includes IL-1α and IL-1β, exhibits strong pro-inﬂammatory
activities and plays amajor role in host responses to exogenous and
endogenous noxious stimuli (Gabay et al., 2010). IL-1 induces the
expression of adhesion molecules on endothelial cells and elicits
stromal cells to release chemokines that promote the recruitment
of inﬂammatory cells at the inﬂammation site (Dinarello, 1996;
Chang et al., 2012; Hu et al., 2012). Such inﬂammation occurs
signiﬁcantly in cases of comorbidity and might contribute to the
increased risk of developing cardiovascular accidents observed in
these patients (Carpagnano et al., 2010). IL-10, a cytokine with
anti-inﬂammatory properties, plays a central role in infection that
involves limiting the immune response to pathogens and thereby
preventing damage to the host (Saraiva and O’Garra, 2010).
Recently, research has shown that IL-10 and related cytokines can
facilitate the tissue-healing process in injuries caused by infection
or inﬂammation (Ouyang et al., 2011). According to these studies,
mediators thought to be involved in the regulation of inﬂamma-
tion responses such as leukocyte recruitment, adhesion molecule
expression, and wound healing in the late phase of inﬂammation.
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IMMUNE CELL-WOUND HEALING
Immune cells are involved in virtually every aspect of the wound
repair process, from the initial stages where they participate in
hemostasis and work to prevent infection to later stages where
they drive scar formation (Wilgus, 2008). Evidence supporting a
central role for T lymphocytes in the control of wound healing is
provided by studies which examine the in vivo effects of alternate
forms of T cell manipulation on various parameters of healing
(Barbul and Regan, 1990) and Neutrophils as important to wound
healing as they help control infection, however, they also release
harmful enzymes which damage healthy tissue surrounding the
wound site (Brubaker et al., 2011). Investigations have enumer-
ated many of the speciﬁc proteins that are produced by wound
macrophages at the site of injury. These include the following: (1)
chemoattractants that recruit and activate additionalmacrophages
at the site of injury, (2) growth factors that promote cellular pro-
liferation and protein synthesis, (3) proteases and extra-cellular
matrix molecules, and (4) factors that may restrain tissue growth
once repair is completed (DiPietro, 1995). Neutrophils arrive ﬁrst
within a few minutes, followed by monocytes and lymphocytes.
They produce a wide variety of proteinases and reactive oxygen
species as a defense against contaminating microorganisms, and
they are involved in the phagocytosis of cell debris. Neutrophil play
a role as primarily phagocytosis appearing approximately 24h after
injury and contribute to decreasing the infection in the wound.
Neutrophils are not paramount to the process of wound healing
or collagen synthesis (Park and Barbul, 2004). Research has been
shown a role of neutrophil in wound healing for the production
of neutrophil growth factors, such as granulocyte/macrophage
colony-stimulating factor (GM-CSF; Canturk et al., 2001). Exper-
iments with cultures of keratinocytes established from −/− and
+/+ mice revealed a retardation in wound closure in CXCR2
−/−keratinocytes, role for this receptor on keratinocytes in epithe-
lial resurfacing that is independent of neutrophil recruitment
(Devalaraja et al., 2000). In the resolution and regeneration stages,
macrophages appear to remove large cell debris as well as apop-
totic neutrophils, the key scavengers for resolving inﬂammation
and facilitating tissue regrowth, furthermore, experiment illus-
trated that the depletion of macrophages in zebraﬁsh model leads
to the delay of the clearance of cell debris, decrease of regener-
ation speed, and formation of vacuoles in the regenerating ﬁn
(Li et al., 2012). Recently, research has shown that wound heal-
ing requires a coordinated interplay among cells, growth factors,
and extracellular matrix proteins. Central to this process is the
endogenous mesenchymal stem cell (MSC), which coordinates
the repair response by recruiting other host cells and secreting
growth factors and matrix proteins. MSCs are self-renewing mul-
tipotent stem cells that can differentiate into various lineages
of mesenchymal origin such as bone, cartilage, tendon, and fat
(Maxson et al., 2012).
FIGURE 2 | Apoptotic immune cell linkage wound healing. When
tissues are damaged, inﬂammatory mediators are released. Where
macrophages and become activated by various cytokines, such as
interferon-γ (IFN-γ), that are released from neighboring inﬂammatory cells,
including neutrophils, natural killer (NK) cells, resident tissue macrophages,
and T cells. In the end of the inﬂammation, we can observe the apoptosis
of the immune cells and the apoptotic cells cleared by macrophages. We
thought that clearance by macrophages of cells apoptosis is a key point
phenomenon associated with actively tissue formation from wound
inﬂammation. The apoptotic immune may drive the conversion of the
immune response into a wound healing response, which is characterized by
the accumulation of macrophages that promote wound healing and ﬁbrosis
through the production of MMPs (including MMP12, tissue inhibitor of
metalloproteinases 1 (TIMPs1), growth factors [including platelet-derived
growth factor (PDGF)], and cytokines [such as transforming growth factor-β1
(TGF-β1)].
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APOPTOTIC CELL-WOUND HEALING
Evidence illustrated that apoptosis is involved in the resolution
of various phases of tissue repair. In the early phases of tis-
sue repair, inﬂammatory cells underwent apoptosis starting as
early as 12 h after wound injured (Brown et al., 1997). Exam-
ined apoptotic patterns in cells in open wounds created in rats,
found that apoptosis marked observed in the inﬂammatory cells
of the scab. In this research found that apoptosis in myoﬁbrob-
lasts initiated on day 12, peaked at day 20, and resolved at day 60.
Theseﬁndings suggest thatmyoﬁbroblast apoptosis initiated about
the same time at the end of the wound following to the healing
(Desmouliere et al., 1995). Stromal keratocyte apoptosis has been
well-characterized as an early initiating event of the corneal wound
healing response, triggering subsequent cellular processes that
include bone marrow-derived cell inﬁltration, proliferation, and
migration of residual keratocyte cells, and, in some circumstances,
generation of myoﬁbroblast cells (Wilson et al., 2007). Impaired
phagocytosis of apoptotic neutrophils by Vav3−/− (guanine-
nucleotide exchange factors implicated in leukocyte functions by
relaying signals from immune response receptors and integrins to
Rho-GTPases) macrophages was causal for their reduced release
of active TGF-β1, for decreasedmyoﬁbroblasts differentiation and
myoﬁbroblast-driven wound contraction to cause the situation
of delayed wound healing (Sindrilaru et al., 2009). Apoptotic cells
released growth signals that stimulated theproliferationof progen-
itor or stem cells by caspases 3 and 7 proteases which involves the
caspase-mediated activation of phospholipase A2 and the subse-
quent production and release of the lipid signal prostaglandin E2,
a stimulator of cell proliferation and mice lacking either of these
caspases were deﬁcient in skin wound healing (Li et al., 2010). We
thought the inﬂammation factors that may be also involved in the
followed healing process. But the question is “what kind of factor
is the major key involved in the end of the inﬂammation then to
initiate the healing.”We suspect that the apoptosis of immune cell
may be the major key to end of inﬂammation and to initiate the
healing as shown in Figure 2.
CONCLUSION
We hypothesized that the key point to end of the inﬂamma-
tion is the apoptotic activity of immune cells. Apoptosis is
considered a vital component of various processes including nor-
mal cell turnover, proper development and functioning of the
immune system, hormone-dependent atrophy, embryonic devel-
opment, and chemical-induced cell death (Elmore, 2007). In
the inﬂammation response, the mediators induce the inﬁltration
of activated immune cells into inﬂammation site to protect the
tissue against the pathogen infection. In the end of the inﬂam-
mation, we can observe the apoptosis of the immune cells and
the apoptotic cells cleared by macrophages. We thought that
clearance by macrophages of cells apoptosis is a key point phe-
nomenon associated with actively tissue formation from wound
inﬂammation.
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